{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:25:13Z","timestamp":1777317913859,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today: Proceedings"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.matpr.2021.08.265","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T05:11:57Z","timestamp":1630645917000},"page":"1258-1264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P5","title":["Therapeutic approaches in COVID-19 followed before arrival of any vaccine"],"prefix":"10.1016","volume":"48","author":[{"given":"Vasundhra","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atul Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.matpr.2021.08.265_b0005","unstructured":"WHO, https:\/\/www.who.int\/csr\/don\/14-january-2020-novel-coronavirus-thailand\/en\/"},{"key":"10.1016\/j.matpr.2021.08.265_b0010","doi-asserted-by":"crossref","unstructured":"C. Rothe, M. Schunk, P. Sothmann, et al., Transmission of 2019-nCoV infection from an asymptomatic contact in Germany, 2020.","DOI":"10.1056\/NEJMc2001468"},{"key":"10.1016\/j.matpr.2021.08.265_b0015","unstructured":"Q. Li, X. Guan, P. Wu, et al., Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, 2020."},{"key":"10.1016\/j.matpr.2021.08.265_b0020","doi-asserted-by":"crossref","unstructured":"A.R. Fehr, S. Perlman, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol. Biol. (2015).","DOI":"10.1007\/978-1-4939-2438-7_1"},{"key":"10.1016\/j.matpr.2021.08.265_b0025","doi-asserted-by":"crossref","unstructured":"R. Dijkman, L. van der Hoek, Human coronaviruses 229E and NL63: close yet still so far, J. Formos. Med. Assoc. (2009).","DOI":"10.1016\/S0929-6646(09)60066-8"},{"key":"10.1016\/j.matpr.2021.08.265_b0030","article-title":"Coronavirus infections in children including COVID19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children","author":"Zimmermann","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.matpr.2021.08.265_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.niox.2020.07.003","article-title":"Harnessing nitric oxide for preventing, limiting and treating the severe pulmonary consequences of COVID-19","author":"Adusumilli","year":"2020","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.matpr.2021.08.265_b0040","article-title":"Clinical course of a critically ill patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","author":"Takahashi","year":"2020","journal-title":"J"},{"key":"10.1016\/j.matpr.2021.08.265_b0045","unstructured":"R. Lu, et al., Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, 2020."},{"key":"10.1016\/j.matpr.2021.08.265_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2951-z","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.matpr.2021.08.265_b0055","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.matpr.2021.08.265_b0060","doi-asserted-by":"crossref","unstructured":"D.H. Alamdari, et al., Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial, Eur. J. Pharmacol. (2020).","DOI":"10.22541\/au.159415252.28995173"},{"key":"10.1016\/j.matpr.2021.08.265_b0065","doi-asserted-by":"crossref","unstructured":"P. Kleinbongard, et al., Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals, Free Radic. Biol. Med. (2003).","DOI":"10.1016\/S0891-5849(03)00406-4"},{"key":"10.1016\/j.matpr.2021.08.265_b0070","doi-asserted-by":"crossref","unstructured":"A.P. Singh, Model for prediction of death rate due to COVID-19 transmission and required precautions, 2020, doi.org\/10.1016\/j.matpr.2020.07.731.","DOI":"10.1016\/j.matpr.2020.07.731"},{"key":"10.1016\/j.matpr.2021.08.265_b0075","doi-asserted-by":"crossref","unstructured":"D.D. Fraser, et al., Endothelial injury and glycocalyx degradation in critically ill coronavirus disease 2019 patients: implications for microvascular platelet aggregation, Crit. Care Explor. 2 (2020).","DOI":"10.1097\/CCE.0000000000000194"},{"key":"10.1016\/j.matpr.2021.08.265_b0080","doi-asserted-by":"crossref","unstructured":"R.C. Becker, COVID-19 update: covid-19-associated coagulopathy, J. Thromb. Thrombolysis (2020).","DOI":"10.1007\/s11239-020-02134-3"},{"issue":"1","key":"10.1016\/j.matpr.2021.08.265_b0085","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000338150","article-title":"The role of nitric oxide and its clinical applications","volume":"122","author":"Levine","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.matpr.2021.08.265_b0090","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.matpr.2021.08.265_b0095","doi-asserted-by":"crossref","unstructured":"H. Li, Z. Liu, J. Ge, Scientific research progress of COVID-19\/SARS-CoV-2 in the first five months, J. Cell Mol. Med. (2020).","DOI":"10.1111\/jcmm.15364"},{"key":"10.1016\/j.matpr.2021.08.265_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.matpr.2021.08.265_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2004.11.035","article-title":"Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate","volume":"208","author":"Bosca","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.matpr.2021.08.265_b0110","article-title":"Weathering the COVID-19 storm: lessons from hematologic cytokine syndromes","author":"England","year":"2020","journal-title":"Blood Rev."},{"issue":"10224","key":"10.1016\/j.matpr.2021.08.265_b0115","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.matpr.2021.08.265_b0120","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and functional basis of SARS-CoV-2 entry by using human ACE2","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.matpr.2021.08.265_b0125","article-title":"Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha","author":"Zheng","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.matpr.2021.08.265_b0130","doi-asserted-by":"crossref","unstructured":"N. Chen, et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet 395 (2020) 507\u2013513, https:\/\/doi.org\/10.1016\/s0140-6736(20)30211-7.","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"10.1016\/j.matpr.2021.08.265_b0135","doi-asserted-by":"crossref","first-page":"6159720","DOI":"10.1155\/2020\/6159720","article-title":"D-dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis","volume":"2020","author":"Long","year":"2020","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.matpr.2021.08.265_b0140","doi-asserted-by":"crossref","unstructured":"E. Callaway, D. Cyranoski, China coronavirus: six questions scientists are asking, 2020.","DOI":"10.1038\/d41586-020-00166-6"},{"key":"10.1016\/j.matpr.2021.08.265_b0145","doi-asserted-by":"crossref","DOI":"10.1021\/acsanm.8b00779","article-title":"Multisite Inhibitors for Enteric Coronavirus: Antiviral Cationic Carbon Dots Based on Curcumin","author":"Ting","year":"2018","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.matpr.2021.08.265_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/1348-0421.12754","article-title":"Gold Nanoparticle-Adjuvanted S Protein Induces a Strong Antigen-Specific IgG Response against Severe Acute Respiratory Syndrome-Related Coronavirus Infection, but Fails to Induce Protective Antibodies and Limit Eosinophilic Infiltration in Lungs","author":"Sekimukai","year":"2020","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.matpr.2021.08.265_b0155","doi-asserted-by":"crossref","unstructured":"Mohd Ahmar Rauf, Munazzah Tasleem, Ketki Bhise, Katyayani Tatiparti, Samaresh Sau, Arun K. Iyer, Nano\u2010therapeutic strategies to target coronavirus. View 2(3) (2021) 20200155. https:\/\/doi.org\/10.1002\/VIW.20200155.","DOI":"10.1002\/VIW.20200155"},{"key":"10.1016\/j.matpr.2021.08.265_b0160","doi-asserted-by":"crossref","first-page":"110924","DOI":"10.1016\/j.msec.2020.110924","article-title":"An Overview of Functional Nanoparticles as Novel Emerging Antiviral Therapeutic Agents","volume":"112","author":"Chen","year":"2020","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.matpr.2021.08.265_b0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","article-title":"Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro","volume":"6","author":"Liu","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.matpr.2021.08.265_b0170","unstructured":"Chloroquine, Drugs.com, Accessed in March 2020. https:\/\/www.drugs.com\/pro\/chloroquine.html."},{"issue":"5","key":"10.1016\/j.matpr.2021.08.265_b0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses\u2014drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.matpr.2021.08.265_b0180","doi-asserted-by":"crossref","first-page":"582025","DOI":"10.3389\/fphar.2020.582025","article-title":"Available compounds with therapeutic potential against Covid-19: antimicrobial therapies, supportive care, and probable vaccines","volume":"6","author":"Kumar","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.matpr.2021.08.265_b0185","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jaim.2017.10.008","article-title":"Unique contributions of Keraleeya Ayurveda in pediatric health care","volume":"9","author":"Chandran","year":"2018","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.matpr.2021.08.265_b0190","unstructured":"Medical Dialogues Bureau, Kerala Plans On Using Ayurveda To Mitigate COVID-19 Spread, 2020. https:\/\/medicaldialogues.in\/state-news\/kerala\/kerala-plans-on-using-ayurveda-to-mitigate-covid-19-spread-64755(accessed on 30th April, 2020)."},{"key":"10.1016\/j.matpr.2021.08.265_b0195","unstructured":"Paul G. Auwaerter, John Hopkins ABX Guide, Coronavirus COVID-19 (SARS-CoV-2), [online] John Hopkins Medicine, last updated on 27.04.2020, accessed on 29.04.2020. https:\/\/www.hopkinsguides.com\/hopkins\/view\/Johns_Hopkins_ABX_Guide\/540747\/all\/Coronavirus_COVI D_19__SARS_CoV_2_."},{"key":"10.1016\/j.matpr.2021.08.265_b0200","unstructured":"Priya Vrat Sharma, editor, translator of Susruta Samhita with English translation of text and Dalhana\u2019s Commentary, Nidana sthana, Kusta Nidana: Chapter 5, verses 33-34. Varanasi: Chaukhambha Visvabharati, First edition, 2000; page 44."},{"key":"10.1016\/j.matpr.2021.08.265_b0205","unstructured":"S. Kissler, C. Tedijanto, M. Lipsitch, Yonatan H. Grad, Social distancing strategies for curbing the COVID-19 epidemic, doi.org\/10.1101\/2020.03.22.20041079."},{"key":"10.1016\/j.matpr.2021.08.265_b0210","unstructured":"South Africa announces a new coronavirus variant, The New York Times. website. https:\/\/www.nytimes.com\/2020\/12\/19\/world\/south-africa-announces-a-new-coronavirus-variant.html."},{"key":"10.1016\/j.matpr.2021.08.265_b0215","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m4857","article-title":"Covid-19: new coronavirus variant is identified in UK","author":"Wise","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.matpr.2021.08.265_b0220","unstructured":"Scientists alarmed at spread of COVID mutant, Financial Times. Website, https:\/\/www.ft.com\/content\/a0bef737-c763-447a-b1f3-0649dc5989a0."},{"key":"10.1016\/j.matpr.2021.08.265_b0225","doi-asserted-by":"crossref","first-page":"m4857","DOI":"10.1136\/bmj.m4857","article-title":"Covid-19: new coronavirus variant is identified in UK","volume":"371","author":"Wise","year":"2020","journal-title":"BMJ"}],"container-title":["Materials Today: Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214785321057096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214785321057096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:08:12Z","timestamp":1762024092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214785321057096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":45,"alternative-id":["S2214785321057096"],"URL":"https:\/\/doi.org\/10.1016\/j.matpr.2021.08.265","relation":{},"ISSN":["2214-7853"],"issn-type":[{"value":"2214-7853","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic approaches in COVID-19 followed before arrival of any vaccine","name":"articletitle","label":"Article Title"},{"value":"Materials Today: Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matpr.2021.08.265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Elsevier Ltd. All rights reserved. Selection and peer-review under responsibility of the scientific committee of the Symposium on Synthesis, Characterization & Processing of Inorganic, bio and nano Materials \u20132021","name":"copyright","label":"Copyright"}]}}